Modification

🛠️What Modifications Need IRB Approval?

All changes to your study, even minor ones, must receive IRB approval before you implement them. For example, changes in inclusion criteria, procedures, recruitment, advertisements, consent forms and questionnaires all require IRB review and approval.

NOTE:

  • Considerable changes to the study’s research plan (e.g., Hypothesis; Aims/Objectives; Procedures; Study design; Scope; Intervention) require the submission of a new study. Modifications to an existing study must fit within the original aims of the study. For example, a No Participant Contact study cannot be modified and made into a Participant Contact study.
  • Implementing changes without IRB approval is a violation of federal regulations and University policies and can lead to the suspension of IRB approval and other serious consequences for the participants, investigators and University.
  • If the study has a protocol provided by a sponsor, cooperative group, or other external organization, and the modification involves changes to that protocol (e.g., changes to inclusion/exclusion criteria, changes to procedures, etc.), you must submit the revised protocol within the Modification SmartForm. Only submitting a Modification SmartForm and revising the IRB Application document is not sufficient.
  • Continue to submit protocol amendments until the study is closed by the sponsor. If enrollment is permanently closed and the new information doesn’t need to be relayed to the study participants, you do not need to submit a revised informed consent form. But you do need to revise the IRB Application document and Study SmartForm (if needed).
  • The IRB does not approve “planned deviations” i.e., planned departures from what the IRB has approved. Please see below for the only exceptions to this. You must follow the IRB-approved materials (e.g., IRB Application, protocol and informed consent forms). If you need to make changes, submit a Modification SmartForm that includes the revised IRB Application, the revised protocol if the study has a protocol, and any other revised study documents such as the informed consent form. For studies in which the UCSF PI does not have protocol control (e.g., some multicenter trials), and the revised protocol has not yet been issued by the sponsor/lead site, you may submit a Modification SmartForm and include a Letter of Amendment from the entity that has protocol control. The Letter of Amendment must describe the upcoming protocol change and when the revised protocol will be submitted to the IRB for review. If the changes described in the Letter of Amendment affect the IRB Study Application, informed consent form, or any other documents, you must make those changes when submitting the Letter of Amendment. 


Exceptions: 

  • Changes “necessary to eliminate apparent immediate hazards to the participant”

    • The requirement for prior IRB review and approval is not required when the changes are “necessary to eliminate apparent immediate hazards to the subject” (45 CFR 46.103.b.4, 21 CFR 56.108.a). In such rare cases, report the actions taken to the IRB within 10 working days using the Protocol Violation or Incident Reporting Form. Seek approval for permanent changes to prevent the hazards in the future.
  • Minor (not significant) changes to exempt research

📋Types of Modifications (Updated July 2026)

NEW JULY 2026: All modifications – including major, minor, administrative, and personnel changes – are submitted using the Modification/CR Form in Research Gateway IRB. The Modification SmartForm will no longer ask you if the modification qualifies as major, minor, or administrative. 

To help aid the IRB’s review of your modification request: 

  • Please thoroughly describe the changes so the IRB can determine the appropriate level of review required.
  • The Principal Investigator must indicate if the changes alter the study’s overall risk/benefit ratio.

The IRB will determine the appropriate level of review based on the nature of the proposed changes and the risks associated with the research. Depending on the changes, a modification may be reviewed by an IRB reviewer using expedited review procedures or by the convened IRB at a full committee meeting.

In general, modifications that involve more significant changes to the study, increase risks to participants, or substantially alter the approved research may require review by the convened IRB. Modifications that involve less significant changes and do not substantially affect the risks, benefits, or overall design of the study may be eligible for expedited review.

Study changes are typically reviewed by the IRB panel that originally reviewed the study. 

OHRP and FDA guidance allows the IRB to use an expedited review procedure to review "minor changes in previously approved research."  The IRB makes the final determination as to whether study changes qualify as “minor changes in previously approved research.”

Below are definitions and examples review levels for modifications. 

IRB committee members identified barriers to efficiently reviewing modifications to complex trials (including umbrella trials and adaptive designs). “Umbrella trials” are studies that assign a particular treatment to a patient based on the type of cancer or unique tumor characteristics, such as molecular markers. Because there are often many treatment arms that come and go based on the study results or other data, the review of modifications can be very challenging. To facilitate IRB review, if you are submitting modifications to complex trials, in addition to completing all sections of the Modification SmartForm, please ensure that the following information is included in the section where modifications are described. Please ensure this information is in lay language, understandable to non-scientists and scientists.

  • Provide a brief general scientific rationale for submitting these changes
  • Describe how the proposed changes fit into the overall progress of the study
  • Describe any removals or additions of study treatment or patient populations
  • Include citations for published articles that support these changes if available

👥Modifications Requiring Full Committee Review

Definition
  1. Any increase in risk to participants is more than minimal; OR;
  2. Any additional activity or procedure would not be eligible for expedited review if submitted as part of new research, OR
  3. The research itself involves more than minimal risk and the changes significantly alter the study design. 
Examples
  1. Increasing major risks or discomforts
  2. Adding or deleting major procedures or diagnostic tests
  3. Restarting a study after a hold for safety concerns
  4. Changing, adding, or deleting drugs, devices, or other treatments being studied may be considered a minor change if it involves substituting approved treatments used in standard ways. This also includes any changes that involve altering the active ingredient or other changes defined in 310.3 as a 'new drug substance'

👤Modifications that can be Reviewed by Expedited Procedures

Definition
  1. Any increase in risk to participants is no more than minimal risk, AND
  2. All additional activities or procedures would be eligible for expedited review if submitted as part of new research, AND;
  3. Either the research itself involves minimal risk or the changes do not significantly alter the study design
Examples
  1. Changing minor procedures or activities without adding more-than-minimal risks
  2. Reducing risks or adding minor risks
  3. Changing wording in the consent form, application or other documents
  4. Adding a new advertisement
  5. Additions or removals of Key Study Personnel (KSP)

Protocol Enrollment Exceptions

As of June 13, 2026, the UCSF IRB does not accept protocol enrollment exception requests. If a Principal Investigator (PI) wishes to enroll a participant who does not meet the IRB-approved eligibility criteria, the protocol must first be revised to incorporate the proposed changes to the eligibility criteria and include a justification for those changes. The IRB will review the revision and, if appropriate, approve the updated eligibility criteria before any participant who does not meet the previously approved criteria may be enrolled. Participants who do not meet the currently IRB-approved eligibility criteria may not be enrolled until the IRB has reviewed and approved the revised protocol. 

💻Submitting in Research Gateway IRB (ReGI) 

Please refer to the ReGI user guides for detailed instructions and screenshots. 

🛠️ 1st Modification for a Migrated Studyexternal site (opens in a new window)Submit the first Modification in ReGI for an approved study migrated from iRIS (for changes beyond non-PI study team member updates).
🛠️ Modifications for Non-Migrated Studies or Migrated Studies With an Approved IRB Application Documentexternal site (opens in a new window)Prepare and submit modifications for studies initially approved in ReGI or for the second and subsequent modifications to studies migrated from iRIS

Here are some submission tips: 

  • Before creating a new Modification SmartForm: If someone other than the PI will submit this to the IRB, they must be listed as a PI Proxy for the study. If not done already, the PI should add the study team members of their choosing to the PI Proxy role. See the user guide: Assign PI Proxies.
  • While completing the Modification SmartForm: Answer the Modification scope question carefully – it cannot be changed after you save the page. 
  • Complete the form and answer every question – even those without red asterisks – unless a question is not applicable to your study.
  • When revising Microsoft Word documents, enable Track Changes so all revisions are visible.
  • If you are uploading a new version of a document that has already been submitted, click Update to upload it as a revision. Do not upload it as a new document.
  • See the Initial Submission Checklist for a list of documents that require IRB review

Reminders:

  • You may combine multiple study changes into a single Modification SmartForm, but only one Modification SmartForm may be submitted at a time. The only exception is that a Modification SmartForm limited to study team member changes may be submitted while another Modification SmartForm for other study changes is under review.
  • If you make several changes to your study at one time, describe each change in detail on the Modification SmartForm. Hold additional modifications until your modification has been approved. Contact the IRB Coordinator assigned to the modification with questions.
  • Some modifications are required in response to Reportable New Information (RNI), such as an adverse event, protocol violation, incident, DSMB/DMC report, sponsor action letter, or other safety report. Whenever possible, submit the Modification SmartForm at the same time as the RNI report.
    • If applicable, link the Modification SmartForm to the RNI report using the Associated Studies field in the RNI Form.
    • If the RNI report and Modification SmartForm cannot be submitted at the same time, explain the reason for the delay in both submissions.

👥Information for Continuing Participants

Per federal regulations, research participants must be informed when there is a significant new finding during the course of research that may affect their willingness to participate [45 CFR 46.116 (b) (5)]. Examples of significant new findings include:

  • New risks or previously described risks that are now found to occur with greater frequency or severity.
  • Changes to the protocol that may affect a subject’s willingness to participate in the research.

If any significant new findings or protocol changes are included in your modification request:

  • Describe how you propose to inform current subjects of this information.
  • Attach any additional consent forms (see our consent form addendum template) or contact letters that will be used for this purpose.

The level of urgency will determine how the information is communicated to participants. See the Adverse Event Reporting Requirements for additional information.

🟢Exempt Research

Only for studies that the IRB has certified as exemptresearchers can make minor changes to the study without notifying the IRB. However, significant changes must be submitted to the IRB. See the examples below.

All changes must follow UCSF guidance, and some changes are not allowed in the consent materials.

Examples of significant changes to Exempt Research: Submit to the IRB

  • Adding a new subject population
  • Adding new procedures
  • Adding a new funding source
  • Adding new collaborators or outside sites (each site must obtain their own Exempt Certification or IRB Approval)
  • Adding questions about sensitive aspects of the subjects’ behavior – such as illegal conduct, drug use, sexual behavior or use of alcohol – to a survey or interview
  • Change in PI
  • Disclosing a new financial interest
  • Any change that makes the study no longer eligible for exemption
  • Revising aims
  • Changes to payment (adding, revising, or removing)

Examples of minor changes to Exempt Research (do not submit to the IRB)

  • Editorial or administrative revisions to consent documents or other study documents
  • Adding non-sensitive questions to a survey or interview, or revising current questions
  • Adding a new recruitment material that follows IRB guidelines
  • Increasing or decreasing the number of subjects, unless you are adding a new subject population
  • Study team/personnel changes (except a change in PI)
    • Note: If new study team members need to edit or access materials in ReGI, you will need to submit a Modification SmartForm to add them to the study (follow the steps below).

🪪Adding or Removing Investigators or Staff

Some of these changes require submission of a Modification SmartForm. Click on the role of the individual you are changing for more info. Review the Research Gateway IRB user guides for step-by-step instructions and screenshots.

UCSF Principal Investigator

Review the Principal Investigator (PI) Change user guide.

Notes: 

  1. A letter signed by the outgoing PI requesting the change
  2. Revised Study SmartForm naming the new PI.
  3. Revised IRB Application document naming the new PI.
  4. Revised consent forms and other participant-facing materials that name the PI.
UCSF Investigators and Staff

Researchers and staff who are Key Study Personnel (KSP):

  • List all UCSF study team members who meet the UCSF definition of KSP in “Key Study Personnel” question in the “Local Study Team Members” section of IRB Study SmartForm. All KSP must have active CITI Human Subjects Protection Training
  • You may also list individuals who are not KSP if they need to edit the study record in ReGI. 
  • See the Study Personnel page for more information on who should be listed on and how to add them. 

Making Study Team Member Changes

If you are only making changes to study team members: Follow the instructions in the Change Study Team Members user guide.

If you are changing study team members and making other study changes (including revisions to consent forms or other participant-facing documents that identify the individuals being changed): Follow the appropriate modification user guide based on the type of changes and whether the study was migrated into ReGI. 

  • Important: In the Modification Scope question on the Modification SmartForm, select both “Study Team Member Information” and “Other Parts of the Study.”

If you need to update a PI Proxy or Primary Contact: These are system roles, not study roles. You do not need to submit a Modification to update them. View the Assign PI Proxies and Assign Primary Contact user guides. 

Exception for exempt research: As explainedfor exempt studies only, you can update KSP (not the PI) tab without submitting a Modification. However, you will need to submit a Modification if these individuals need to access or edit the study record in ReGI.

Staff from a UCSF-Affiliated Institution

Please review our list of UCSF-affiliated institutions.

UCSF-affiliated personnel should be listed in the IRB Study SmartForm and have active CITI Human Subjects Protection Training if they meet the UCSF definition of KSP.  

The process for listing affiliated KSP varies depending on whether the individual needs access to ReGI or other UC network systems:

  • Affiliated KSP who need access to ReGI or other UC network programs: List them in the “Key Study Personnel” question in the IRB Study SmartForm.
  • Affiliated KSP who do NOT need access to ReGI or other UC network programs: Follow the instructions in the “Affiliated Personnel” question in the IRB Study SmartForm. Attach the Affiliated Study Personnel Form and CITI Human Subjects Protection training completion certificates for all individuals listed on the form.

See the Study Personnel page for more information.

Staff from the San Francisco Veterans Affairs Medical Center (SFVAHCS)

VA staff must be up to date on their UCSF-VA CITI training. The SFVAHCS requires regular training for all individuals engaged in research with human subjects, their tissue or data. If you are working at the SFVAMC, we recommend completion of the VA CITI training, which will meet UCSF’s requirements.

If the individual is also a UCSF employee (dual appointment at SFVAHCS and UCSF), follow the instructions above for adding UCSF Investigators and Staff.

If the individual is not also a UCSF employee, follow the instructions above for adding Staff from a UCSF-Affiliated Institution.  

Visiting Faculty
Students

Students may join a research team for the specific purpose of gaining academic credit or professional advancement. Students are not considered volunteers, per Campus Volunteer Guidelines, and therefore their work on a study team must be guided by an appropriate affiliation or professional service agreement.

Students should be listed in the IRB Study SmartForm and have active CITI Human Subjects Protection Training if they meet the UCSF definition of Key Study Personnel

See the Study Personnel page for more information.

Volunteers

UCSF: Volunteers are not permitted to work on research studies at UCSF, per UCSF Campus Volunteer Guidelines

SFVAHCS: Volunteers can work on research studies at the SF Veterans Affairs Health Care System. To add a volunteer to the study application, follow the instructions above for adding Staff from a UCSF-Affiliated Institution.

💰 Changing or Adding Funding Info 

You must submit a modification to the IRB to add a new funding source to an approved study. The IRB must approve the modification before the Office of Sponsored Research (OSR) may accept the new award. OSR administrators have access to ReGI and can verify approval of the new funding source.

Submit a Modification SmartForm and describe the new funding source. Attach the following items:

1. A revised IRB Study SmartForm 

"Funding" section:

  1. Indicate "Yes" for the federal funding question if your study receives any federal funds, even if they come through a subcontract or another source from the prime awardee.
  2. Add the new funding source. If your study includes a subcontract, specify the prime sponsor, such as the NIH.
  3. For all studies with funding through UCSF, either the Award Number (A Number) OR the Proposal Number (P Number) is required. The A Number should be added when other changes are being submitted.
  4. If applicable, list the grant title and PI, and explain any significant discrepancies between the IRB application and the grant or contract.

Local Study Team Members section: The PI of the award must be listed as an investigator on the IRB Study SmartForm, so update this section, if necessary.

2. Consent documents (if applicable)Update the consent document(s) if the sponsor info needs to be changed.

Removing a Funding Source: Please do not remove a funding source from the IRB Study SmartForm if funding has ended. You can remove a sponsor if the study was never funded (e.g. a grant was submitted, but not funded).

Changing RAS Proposal numbers (P#) to Award numbers (A#): The IRB requires either a P# or an A# at the time the funding source is added, not both, but the A Number is needed at the time of the next Modification.  Do not submit a Modification only to add the A Number, but please include it at the time that other changes are being made.

🏢 Changing or Adding Sites

Most site additions require changes in the IRB Study SmartForm (“Local Research Locations” section), consent form, and the IRB Application document — especially the “Setting,” "Procedures Involved," "Inclusion and Exclusion Criteria" and "Recruitment" sections. You may also need to change your recruitment documents.

In general, the IRB at the new site must approve the study before work can begin there. See the Working With Other Institutions page for more info. 

If you are adding a site that is affiliated with UCSF, see the UCSF Affiliated Institutions page.

📍Changing Locations within UCSF

If you move to another UCSF campus (e.g., from Parnassus to Mission Bay), the study site and address need to be updated in the consent form. A Modification SmartForm needs to be submitted, but can be batched with your next, upcoming submission. A separate Modification SmartForm does not have to be submitted solely to update the address.

💼 Changes in Researchers’ Financial Interests

Report any changes the researchers’ financial interests related to the study to the Conflict of Interest Advisory Committee (COIAC). The COIAC will advise the PI and the IRB if modifications in the study are needed.

If there are changes in researchers’ financial interests that have not yet been reported to the IRB at the time of a modification, update the IRB Study SmartForm and describe the change in the Modification SmartForm.

 

Last updated: